Filgotinib(Jyseleca)

Another NameJyseleca,Fequintinib,非戈替尼

IndicationsAdult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to various disease modifying antirheumatic drugs (DMARD).